SUNSHINE PHARMA(06887.HK) closed 23.71% lower, leading declines in the Hang Seng Pharmaceuticals & Biotechnology Sector

NewTimeSpace (newtimespace.com) News, By the close of trading on Jul 17, 2026, SUNSHINE PHARMA(06887.HK) saw a loss of 23.71% in its share price, closing at HKD 28. During the session, it reached an intraday high of HKD 38 and touched an intraday low of HKD 15.01. The full-day turnover stood at HKD 250.32 million, with significant volume growth, with the latest market capitalization at HKD 8.97 billion.

On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which SUNSHINE PHARMA belongs, showed an overall broad declines trend, with 14 stocks advancing and 137 stocks declining.Among the gainers, MODERN CHI MED closed higher by 9.2%, MEGA GENOMICS closed higher by 7.81%, BIOSINO BIO-TEC closed higher by 5.65%, UNI-BIO GROUP closed higher by 3.95%, B&K CORP-B closed higher by 3.58%.Among the decliners, SUNSHINE PHARMA closed lower by 23.71%, ASCLETIS-B closed lower by 21.04%, CLOVER BIO-B closed lower by 18.23%, EVEREST MED closed lower by 15.11%, 160 HEALTH closed lower by 13.64%.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.